Use of fluorescence in situ hybridization to distinguish metastatic uveal from cutaneous melanoma

International Journal of Surgical Pathology

Volumn 20, Issue 3, 2012, Pages 246-251

  Fang, Yuqiang ^a   Wang, Xuan ^b   Dusza, Stephen ^a   Jhanwar, Suresh ^a   Abramson, David ^a   Busam, Klaus J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

FISH; melanoma; metastasis

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BCL6 GENE; CEP3 GENE; CHROMOSOME 1P; CHROMOSOME 3; CHROMOSOME 8Q; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; HUMAN; HUMAN TISSUE; MALE; MELANOMA SKIN CANCER; METASTASIS; MONOSOMY; MONOSOMY 3; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; UVEA MELANOMA;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; UVEAL NEOPLASMS; YOUNG ADULT;

EID: 84861628940     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896912438589     Document Type: Article

References (33)

1. Hussein MR. Extracutaneous malignant melanomas. Cancer Invest. 2008 ; 26: 516-534
2. Singh AD, Bergman L, Seregard S. Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am. 2005 ; 18: 75-84
3. Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB. Variates of survival in metastatic uveal melanoma. J Clin Oncol. 2005 ; 23: 8076-8080
4. Rose DM, Essner R, Hughes TM, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg. 2001 ; 136: 950-955
5. Shildkrot Y, Wilson MW. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease. Curr Opin Ophthalmol. 2009 ; 20: 504-510
6. Flaherty KT, Hodi FS, Bastian BC. Mutation-driven drug development in melanoma. Curr Opin Oncol. 2010 ; 22: 178-183
7. Vultur A, Villanueva J, Herlyn M. Targeting BRAF in advanced melanoma: a first step toward manageable disease. Clin Cancer Res. 2011 ; 17: 1658-1663
8. Wan PT, Garnett MJ, Roe SM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004 ; 116: 855-867
9. Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011 ; 364: 2507-2516
10. Luke JJ, Hodi FS. Vemurafenib and BRAF inhibition: a new class of treatment for metastatic melanoma. Clin Cancer Res. 2012 ; 18: 9-14
11. Kimple AJ, Bosch DE, Giguère PM, Siderovski DP. Regulators of G-protein signaling and their Galpha substrates: promises and challenges in their use as drug discovery targets. Pharmacol Rev. 2011 ; 63: 728-749
12. Patel M, Smyth E, Chapman PB, et al. Therapeutic implications of the emerging molecular biology of uveal melanoma. Clin Cancer Res. 2011 ; 17: 2087-2100
13. Van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2009 ; 457: 599-602
14. Balaban G, Herlyn M, Guerry D, et al. Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet. 1984 ; 11: 429-439
15. Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res. 1998 ; 58: 2170-2175
16. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005 ; 353: 2135-2147
17. Limon J, Dal Cin P, Sait SN, Karakousis C, Sandberg AA. Chromosome changes in metastatic human melanoma. Cancer Genet Cytogenet. 1988 ; 30: 201-211
18. Hoglund M, Gisselsson D, Hansen GB, et al. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer. 2004 ; 108: 57-65
19. Prescher G, Bornfeld N, Becher R. Nonrandom chromosomal abnormalities in primary uveal melanoma. J Natl Cancer Inst. 1990 ; 82: 1765-1769
20. Horsman DE, Sroka H, Rootman J, White VA. Monosomy 3 and isochromosome 8q in a uveal melanoma. Cancer Genet Cytogenet. 1990 ; 45: 249-253
21. Sisley K, Rennie IG, Cottam DW, Potter AM, Potter CW, Rees RC. Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3, 6, and 8. Genes Chromosomes Cancer. 1990 ; 2: 205-209
22. van den Bosch T, Kilic E, Paridaens D, de Klein A. Genetics of uveal melanoma and cutaneous melanoma: two of a kind?. Dermatol Res Pract. 2010 ; 2010: 360136
23. Kraehn GM, Utikal J, Udart M, et al. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases. Br J Cancer. 2001 ; 84: 72-79
24. Parrella P, Caballero OL, Sidransky D, Merbs SL. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization. Invest Ophthalmol Vis Sci. 2001 ; 42: 1679-1684
25. Kilic E, Naus NC, van Gils W, et al. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci. 2005 ; 46: 2253-2257
26. Singh AD, Tubbs R, Biscotti C, Schoenfield L, Trizzoi P. Chromosomal 3 and 8 status within hepatic metastasis of uveal melanoma. Arch Pathol Lab Med. 2009 ; 133: 1223-1227
27. Albihn A, Johnsen JI, Henriksson MA. MYC in oncogenesis and as a target for cancer therapies. Adv Cancer Res. 2010 ; 107: 163-224
28. Lee JH, Choi JW, Kim YS. Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis. Br J Dermatol. 2011 ; 164: 776-784
29. Rimoldi D, Salvi S, Lienard D, et al. Lack of BRAF mutations in uveal melanoma. Cancer Res. 2003 ; 63: 5712-5715
30. Van Raamsdonk CD, Griewank KG, Crosby MB, et al. Mutations in GNA11 in uveal melanoma. N Engl J Med. 2010 ; 363: 2191-2199
31. Bonaldi L, Midena E, Filippi B, et al. FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas. J Cancer Res Clin Oncol. 2008 ; 134: 1123-1127
32. Busam KJ. Metastatic melanoma to the skin simulating blue nevus. Am J Surg Pathol. 1999 ; 23: 276-282
33. Wieselthier JS, White WL. Cutaneous metastasis of ocular malignant melanoma. An unusual presentation simulating blue nevi. Am J Dermatopathol. 1996 ; 18: 289-295